CDK4 and cervical cancer: Quantitativeproteomic profiling of ML 1–71 in C33A cervical cancer cellsalso demonstrated relatively selective CDK4 degradation with only15 other targets reduced in levels that may arise from transcriptionaleffects downstream of CDK4 inhibition or off-target effects (Figure 5g; Table S5).